CANscript provides a pre-clinical model that is backed by clinical correlation studies across various cancer types and drug classes. Traditional models such as mouse models and cell lines don’t provide the entire picture and lack a strong clinical correlation. Only Mitra Biotech offers access to a technology that:

  • Utilizes fresh matched tumor tissue and autologous ligands
  • Accurately recreates the tumor microenvironment as found in patient, and
  • Has been developed and validated by following thousands of clinical cases.

CANscript is a reliable model system that dramatically streamlines oncology drug development by helping to answer key questions. Utilize M-Score to make decisions on the basis of response or interrogate CANscript to determine MOA of compounds. Harness the power of our platform to drive true insight.